Ying Du

Director Ejecutivo en ZAI LAB LIMITED .

Fortuna: 19 M $ al 30/04/2024

59 años

100 relaciones

Health Technology

Finance

Consumer Services

Perfil

Fundador de Zai Lab Ltd., Hutchison MediPharma Ltd. y Zai Venture Partners, Ying Du es un empresario que ocupa el cargo de presidente y director general de Zai Lab Ltd. y socio general de Zai Venture Partners (una filial de Zai Lab Ltd.). El Dr. Du también forma parte del consejo de administración de Eden Biologics, Inc. En el pasado, el Dr. Du ocupó los cargos de Director General de Hutchison MediPharma Ltd., Director Científico de Hutchison China MediTech Ltd., Vicepresidente Ejecutivo de Inversiones Sanitarias de Hutchison Whampoa (China) Ltd. y Socio de Riesgo de Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du se doctoró en la Universidad de Cincinnati (Ohio) y se licenció en la Universidad de Jilin.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
ZAI LAB LTD. 1.12%	12/04/2024	11 130 910 ( 1.12% )	19 M $	30/04/2024

Cargos activos de Ying Du

Empresas	Cargo	Inicio
ZAI LAB LIMITED	Director Ejecutivo	01/04/2014
JHL BIOTECH, INC.	Director/Miembro de la Junta	17/12/2012
Zai Venture Partners Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017.	Fundador	01/01/2017

Todos los cargos activos de Ying Du

Antiguos cargos conocidos de Ying Du.

Empresas	Cargo	Fin
Hongshan Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong.	Inversor de Capital Privado	-
Hutchison Whampoa (China) Ltd. Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980.	Corporate Officer/Principal	-
HUTCHMED (CHINA) LIMITED	Director Técnico/Científico/I+D	-
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Director Ejecutivo	-

Ver el detalle de la experiencia de Ying Du.

Formación de Ying Du.

University of Cincinnati (Ohio)	Doctorate Degree
Jilin University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ying Du.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
HUTCHMED (CHINA) LIMITED	Health Technology
ZAI LAB LIMITED	Health Technology

Empresas privadas	5
Hutchison MediPharma Ltd. Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.	Health Technology
Hutchison Whampoa (China) Ltd. Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980.	Finance
Eden Biologics, Inc. Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan.	Health Technology
Hongshan Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong.	Finance
Zai Venture Partners Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017.	Finance

Ver las conexiones de la empresa